Ademi LLP is investigating Maxar (NYSE:MAXR) for possible breaches of fiduciary duty and other violations of law in its transaction with Advent.
Ademi LLP alleges Maxar’s financial outlook and prospects are excellent and yet Maxar shareholders will receive only $53.00 per share in cash. The transaction agreement unreasonably limits competing bids for Maxar by imposing a significant penalty if Maxar accepts a superior bid. Maxar insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of Maxar’s board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Maxar.